MedTrace Logo

Additional Effect of Forward Head Posture Correction on Temporomandibular Dysfunction

NCT06156345 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2024-05-23

No results posted yet for this study

Summary

The goal of this clinical trial is to test the additional correction effect of nerd neck on damaged jaw in people who suffers from jaw problems and nerd neck at the same time. The main question it aims to answer:

• whether the additional correction of nerd neck impact the jaw features of pain and function.

Participants will:

* participants will be given the consent to sign first.
* participants will be assessed to check jaw pain and function.
* participants will be divided randomly into 2 groups.
* Each group will be given the treatment sessions for 6 weeks.
* participants will come back after 6 weeks for another last assessment. Researchers will compare regular treatment for Jaw with new device, regular only and dental treatment groups to see if there is improvement in jaw characteristics.

Conditions

  • Temporomandibular Disorder
  • Forward Head Posture

Interventions

DEVICE

Conservative with Denneroll

Denneroll cervical traction orthodontic traction for 3 to 15 minutes once daily with conservative management of stretching and relaxation.

OTHER

Conservative

conservative management of stretching and relaxation with placebo traction.

Sponsors & Collaborators

  • Shima Abdollah Mohammad Zadeh

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2025-02-28
Completion
2025-12-31

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06156345 on ClinicalTrials.gov